Author
Listed:
- Maria Stella Ritorto
(MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee)
- Richard Ewan
(MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee)
- Ana B. Perez-Oliva
(MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee)
- Axel Knebel
(MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee)
- Sara J. Buhrlage
(Dana-Farber Cancer Institute
Harvard Medical School)
- Melanie Wightman
(MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee)
- Sharon M. Kelly
(Institute of Molecular Cell and Systems Biology, University of Glasgow)
- Nicola T. Wood
(MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee)
- Satpal Virdee
(MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee)
- Nathanael S. Gray
(Dana-Farber Cancer Institute
Harvard Medical School)
- Nicholas A. Morrice
(The Beatson Institute for Cancer Research, Bearsden)
- Dario R. Alessi
(MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee)
- Matthias Trost
(MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee)
Abstract
Deubiquitylases (DUBs) are key regulators of the ubiquitin system which cleave ubiquitin moieties from proteins and polyubiquitin chains. Several DUBs have been implicated in various diseases and are attractive drug targets. We have developed a sensitive and fast assay to quantify in vitro DUB enzyme activity using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Unlike other current assays, this method uses unmodified substrates, such as diubiquitin topoisomers. By analysing 42 human DUBs against all diubiquitin topoisomers we provide an extensive characterization of DUB activity and specificity. Our results confirm the high specificity of many members of the OTU and JAB/MPN/Mov34 metalloenzyme DUB families and highlight that all USPs tested display low linkage selectivity. We also demonstrate that this assay can be deployed to assess the potency and specificity of DUB inhibitors by profiling 11 compounds against a panel of 32 DUBs.
Suggested Citation
Maria Stella Ritorto & Richard Ewan & Ana B. Perez-Oliva & Axel Knebel & Sara J. Buhrlage & Melanie Wightman & Sharon M. Kelly & Nicola T. Wood & Satpal Virdee & Nathanael S. Gray & Nicholas A. Morric, 2014.
"Screening of DUB activity and specificity by MALDI-TOF mass spectrometry,"
Nature Communications, Nature, vol. 5(1), pages 1-11, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5763
DOI: 10.1038/ncomms5763
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5763. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.